Patrick Rüdelsheim obtained his PhD in biology/botany at the University of Antwerp, Belgium.
He started his career in D.J. Vanderhave B.V., a Dutch Seed company where he was involved in the application of plant cell biology in classical breeding. In 1990, he joined Plant Genetic Systems N.V., Ghent, Belgium as Field Trial Supervisor. After being in charge of Product Development and Registration, he was appointed Director Regulatory Affairs and Member of the PGS Board. During subsequent mergers and acquisitions he became Global Head Regulatory Affairs BioScience with respectively AgrEvo, Aventis CropScience and Bayer CropScience. In 2003, he founded and became General Partner of PERSEUS BVBA, a service company focused on biosafety and related regulatory requirements. PERSEUS focuses on Europe, being registered in Belgium, in one of Europe's most active Life Science regions and close to the European Commission's administrative centres. PERSEUS encompasses the full spectrum of biosafety and regulatory disciplines for biologicals, genetically modified or not. In particular for genetically modified material, PERSEUS offers extensive expertise in all phases beyond containment (e.g. field trials, commercial applications, movement of materials and imports).
Relevant experience:
- First hand experience in obtaining approvals for and performing field trials with genetically modified plants in several EU countries and internationally, acquired over 15 years.
- Submitted and managed placing on the market applications for the introduction of genetically modified oilseed rape in EU.
- Supervised submission of subsequent Deliberate Release and GM Food & Feed applications (corn, cotton, rice).
- Involved in public biosafety research collaborations and in corporate product defence, Recognized risk assessment and management expert (in 2006 he was nominated by Belgium to the "roster of experts on Biosafety" of the Cartagena Protocol on Biosafety.
- Member of key associations and working groups, including member of International Society for Biosafety Research and since 2004 member of its Executive Board, member of European BioSafety Association and Chairman of the Safety in Biotechnology Task Group of the European Federation of Biotechnology.
He is a co-founder of ABTR Network.
|
